Anti-HINT2/ HIT-17 functional antibody

Anti-HINT2/ HIT-17 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to HINT2/HINT2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1506-Ab-1/ GM-Tg-hg-SE1506-Ab-2Anti-Human HINT2 monoclonal antibodyHuman
GM-Tg-rg-SE1506-Ab-1/ GM-Tg-rg-SE1506-Ab-2Anti-Rat HINT2 monoclonal antibodyRat
GM-Tg-mg-SE1506-Ab-1/ GM-Tg-mg-SE1506-Ab-2Anti-Mouse HINT2 monoclonal antibodyMouse
GM-Tg-cynog-SE1506-Ab-1/ GM-Tg-cynog-SE1506-Ab-2Anti-Cynomolgus/ Rhesus macaque HINT2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1506-Ab-1/ GM-Tg-felg-SE1506-Ab-2Anti-Feline HINT2 monoclonal antibodyFeline
GM-Tg-cang-SE1506-Ab-1/ GM-Tg-cang-SE1506-Ab-2Anti-Canine HINT2 monoclonal antibodyCanine
GM-Tg-bovg-SE1506-Ab-1/ GM-Tg-bovg-SE1506-Ab-2Anti-Bovine HINT2 monoclonal antibodyBovine
GM-Tg-equg-SE1506-Ab-1/ GM-Tg-equg-SE1506-Ab-2Anti-Equine HINT2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1506-Ab-1/ GM-Tg-hg-SE1506-Ab-2; GM-Tg-rg-SE1506-Ab-1/ GM-Tg-rg-SE1506-Ab-2;
GM-Tg-mg-SE1506-Ab-1/ GM-Tg-mg-SE1506-Ab-2; GM-Tg-cynog-SE1506-Ab-1/ GM-Tg-cynog-SE1506-Ab-2;
GM-Tg-felg-SE1506-Ab-1/ GM-Tg-felg-SE1506-Ab-2; GM-Tg-cang-SE1506-Ab-1/ GM-Tg-cang-SE1506-Ab-2;
GM-Tg-bovg-SE1506-Ab-1/ GM-Tg-bovg-SE1506-Ab-2; GM-Tg-equg-SE1506-Ab-1/ GM-Tg-equg-SE1506-Ab-2
Products NameAnti-HINT2 monoclonal antibody
Formatmab
Target NameHINT2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-HINT2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1506-Ag-1Recombinant multi-species HINT2/ HIT-17 protein
    ORF Viral VectorvGMLP000713human HINT2 Lentivirus particle
    ORF Viral VectorpGMLP000713human HINT2 Lentivirus plasmid
    ORF Viral VectorpGMLPm002575mouse Hint2 Lentivirus plasmid
    ORF Viral VectorvGMLPm002575mouse Hint2 Lentivirus particle


    Target information

    Target IDGM-SE1506
    Target NameHINT2
    Gene ID84681,68917,313491,695521,481599,101094547,281816,106782580
    Gene Symbol and Synonyms1190005L05Rik,HINT2,HIT-17
    Uniprot AccessionQ9BX68,Q8SQ21
    Uniprot Entry NameHINT2_HUMAN,HINT2_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000137133
    Target ClassificationN/A

    The target: HINT2, gene name: HINT2, also named as HIT-17. Histidine triad proteins, such as HINT2, are nucleotide hydrolases and transferases that act on the alpha-phosphate of ribonucleotides (Brenner, 2002 [PubMed 12119013]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.